These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. Amano K; Leung PS; Rieger R; Quan C; Wang X; Marik J; Suen YF; Kurth MJ; Nantz MH; Ansari AA; Lam KS; Zeniya M; Matsuura E; Coppel RL; Gershwin ME J Immunol; 2005 May; 174(9):5874-83. PubMed ID: 15845458 [TBL] [Abstract][Full Text] [Related]
23. Differing epitope selection of experimentally-induced and natural antibodies to a disease-specific autoantigen, the E2 subunit of pyruvate dehydrogenase complex (PDC-E2). Rowley MJ; Maeda T; Mackay IR; Loveland BE; McMullen GL; Tribbick G; Bernard CC Int Immunol; 1992 Nov; 4(11):1245-53. PubMed ID: 1282029 [TBL] [Abstract][Full Text] [Related]
24. Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis. Implication for a conformational autoepitope. Surh CD; Coppel R; Gershwin ME J Immunol; 1990 May; 144(9):3367-74. PubMed ID: 1691756 [TBL] [Abstract][Full Text] [Related]
25. Autoreactive liver-infiltrating T cells in primary biliary cirrhosis recognize inner mitochondrial epitopes and the pyruvate dehydrogenase complex. Löhr H; Fleischer B; Gerken G; Yeaman SJ; Meyer zum Büschenfelde KH; Manns M J Hepatol; 1993 Jul; 18(3):322-7. PubMed ID: 7693799 [TBL] [Abstract][Full Text] [Related]
26. Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis? Butler P; Hamilton-Miller J; Baum H; Burroughs AK Biochem Mol Biol Int; 1995 Mar; 35(3):473-85. PubMed ID: 7773184 [TBL] [Abstract][Full Text] [Related]
27. [The association between autoantibodies to enzyme and diseases--with special reference to antibodies to pyruvate dehydrogenase complex (PDH)]. Moteki S; Amaki S; Nakano E Rinsho Byori; 1998 Apr; 46(4):317-23. PubMed ID: 9594621 [TBL] [Abstract][Full Text] [Related]
28. Reactivity of anti-mitochondrial autoantibodies in primary biliary cirrhosis: definition of two novel mitochondrial polypeptide autoantigens. Frazer IH; Mackay IR; Jordan TW; Whittingham S; Marzuki S J Immunol; 1985 Sep; 135(3):1739-45. PubMed ID: 2410503 [TBL] [Abstract][Full Text] [Related]
29. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. Shimoda S; Van de Water J; Ansari A; Nakamura M; Ishibashi H; Coppel RL; Lake J; Keeffe EB; Roche TE; Gershwin ME J Clin Invest; 1998 Nov; 102(10):1831-40. PubMed ID: 9819369 [TBL] [Abstract][Full Text] [Related]
30. Heterogeneous response of antimitochondrial autoantibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2: the molecule versus the mimic. Migliaccio C; Van de Water J; Ansari AA; Kaplan MM; Coppel RL; Lam KS; Thompson RK; Stevenson F; Gershwin ME Hepatology; 2001 Apr; 33(4):792-801. PubMed ID: 11283841 [TBL] [Abstract][Full Text] [Related]
31. Sera from patients with tuberculosis recognize the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis. Klein R; Wiebel M; Engelhart S; Berg PA Clin Exp Immunol; 1993 May; 92(2):308-16. PubMed ID: 7683589 [TBL] [Abstract][Full Text] [Related]
32. The X and why of xenobiotics in primary biliary cirrhosis. Rieger R; Gershwin ME J Autoimmun; 2007; 28(2-3):76-84. PubMed ID: 17360156 [TBL] [Abstract][Full Text] [Related]
33. The pyruvate dehydrogenase complex as a target autoantigen in primary biliary cirrhosis. Nishio A; Coppel R; Ishibashi H; Gershwin ME Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):535-47. PubMed ID: 10976013 [TBL] [Abstract][Full Text] [Related]
34. Molecular aspects and the pathological basis of primary biliary cirrhosis. Leung PS; Van de Water J; Coppel RL; Nakanuma Y; Munoz S; Gershwin ME J Autoimmun; 1996 Apr; 9(2):119-28. PubMed ID: 8738955 [TBL] [Abstract][Full Text] [Related]
35. Autoantibodies in primary biliary cirrhosis: analysis of reactivity against eukaryotic and prokaryotic 2-oxo acid dehydrogenase complexes. Fussey SP; Lindsay JG; Fuller C; Perham RN; Dale S; James OF; Bassendine MF; Yeaman SJ Hepatology; 1991 Mar; 13(3):467-74. PubMed ID: 1999318 [TBL] [Abstract][Full Text] [Related]
36. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Miyakawa H; Tanaka A; Kikuchi K; Matsushita M; Kitazawa E; Kawaguchi N; Fujikawa H; Gershwin ME Hepatology; 2001 Aug; 34(2):243-8. PubMed ID: 11481607 [TBL] [Abstract][Full Text] [Related]
37. Characterization of a lipoyl domain-independent B-cell autoepitope on the human branched-chain acyltransferase in primary biliary cirrhosis and overlap syndrome with autoimmune hepatitis. Csepregi A; Obermayer-Straub P; Kneip S; Kayser A; Loges S; Schmidt E; Nemesánszky E; Szalay F; Manns MP; Strassburg CP Clin Dev Immunol; 2003; 10(2-4):173-81. PubMed ID: 14768949 [TBL] [Abstract][Full Text] [Related]
38. Inhibitory autoantibody to a conformational epitope of the pyruvate dehydrogenase complex, the major autoantigen in primary biliary cirrhosis. Rowley MJ; McNeilage LJ; Armstrong JM; Mackay IR Clin Immunol Immunopathol; 1991 Sep; 60(3):356-70. PubMed ID: 1713816 [TBL] [Abstract][Full Text] [Related]
39. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. Van de Water J; Ansari AA; Surh CD; Coppel R; Roche T; Bonkovsky H; Kaplan M; Gershwin ME J Immunol; 1991 Jan; 146(1):89-94. PubMed ID: 1984455 [TBL] [Abstract][Full Text] [Related]